The drug trastuzumab deruxtecan improves progression-free survival in HER2-positive breast cancer in 75.8% of patients. The results of the study, led by the International Breast Cancer Center and published in The New England Journal of Medicine, are “the most positive in history,” according to the authors.
–
Related posts:
The Risk of Getting Covid-19 in Restaurants is Greater
Junta de Castilla y León allocates 76 million euros for health services in 2024 Budget Law
Child Tests Positive for Polio Virus in Central Java: Vaccination Campaign Launched in Sleman
Types of flora and fauna that live in the savanna, what is the savanna and its location?
:strip_icc():format(jpeg)/kly-media-production/medias/2841654/original/096329800_1561972203-tbc.jpg "Recognize Early, Here Are 5 Signs of Tuberculosis Lung Disease")
